Home › Funds › Woodline Partners LP › TNGX

Woodline Partners LP position in TNGX

TANGO THERAPEUTICS INC · Health Care

Woodline Partners LP reported holding 4,000,567 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$125.1M, representing 0.39% of its reported portfolio and ranking #50 among its reported holdings. Woodline Partners LP has disclosed TNGX holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.00M sh
Reported value held$125.06M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Woodline Partners LP's TNGX position evolved

Woodline Partners LP first disclosed a stake in TNGX in Q3 2023 at 250,000 shares (US$2.8M). The position peaked in Q1 2026 at 8,000,013 shares, worth US$167.4M. Across 9 filings, Woodline Partners LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,000,567 shares valued at US$125.1M — a reduction of -3,999,446 shares quarter over quarter.. Notable position changes include a 1091% increase in Q2 2025 (shares rose 64% over the following quarter), a 67% increase in Q4 2025 (shares rose 136% over the following quarter), a 50% trim in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 250.00K $2.81M New
Q2 2024 348.09K $2.99M New
Q4 2024 394.40K $1.22M New
Q1 2025 506.19K $693.48K Add
Q2 2025 6.03M $30.87M Add
Q3 2025 6.03M $50.65M Hold
Q4 2025 10.07M $89.24M Add
Q1 2026 8.00M $167.36M Reduce
Q2 2026 4.00M $125.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Woodline Partners LP held TNGX?

Woodline Partners LP has disclosed TNGX holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Woodline Partners LP's current position in TNGX?

As of Q2 2026, Woodline Partners LP holds 4.00M shares of TNGX (TANGO THERAPEUTICS INC), valued at $125.06M, representing 0.39% of its reported portfolio and ranking #50.

Has Woodline Partners LP been buying or selling TNGX?

In the latest 13F filing (Q2 2026), Woodline Partners LP reduced its position in TNGX. The position peaked in Q1 2026 at 8.00M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 84 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.